Because WT mice infected with GBS COH1 displayed both increased bacterial burdens and mast cell numbers in the bladder at 24 h postinfection, we next assessed if mast cell inhibition might improve host outcomes during GBS UTI. The gene discussed is VPS13B; the disease is Guillain-Barre syndrome.